Expanding Treatment Offerings CleanSlate recently launched a new treatment offering in June 2025, signaling ongoing product development and potential upsell opportunities to existing centers and referral partners seeking integrated MAT and behavioral health services.

National Reach with Growth With over 70 centers nationwide and a revenue range of 100M-250M, CleanSlate demonstrates scale and a proven model that can be replicated or franchised through partnerships, acquisitions, or co-located services with health systems.

Clinical Leadership Stability Recent leadership appointments including a Chief Medical Officer and continued clinical leadership continuity suggest a stable, patient-focused strategy favorable for enterprise-level collaborations and health plan negotiations.

Comprehensive MAT Capabilities Strength in medication-assisted treatment for opioid and alcohol use disorders plus specialized services (Hep C screening/treatment, OUD pregnancy care, fentanyl withdrawal) creates cross-sell opportunities to integrated care networks and payer programs seeking end-to-end addiction care.

Data-Driven Care Quality High reported outcomes such as a 90% negative opioid test rate after 12 weeks indicate strong performance metrics that can support value-based contracting discussions, patient outcomes messaging, and performance-based partnerships.